FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
Source: The Hill News · Bias: Center
Summary
The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Wegovy. The FDA wrote in a March 5 letter that it observed “serious violations” of reporting requirements during…
Related Coverage
- Billionaire Tech Mogul Peter Thiel Warns Woke AI Company Anthropic Could Rig 2028 Election for Democrats (Far Right — The Gateway Pundit)
- Melania gives Congress private deadline as she works around Trump's team: report (Far Left — Raw Story)
- REPORT: Acting DNI Bill Pulte Fires Dozens of ODNI Staff for Politicizing Intelligence, Insubordination, Gross Misconduct (Far Right — The Last Refuge)
- Fox host warns Trump will pay for his 'breathtaking' corruption (Left — Alternet.org)
- Bannon warns the ‘old politics are gone’ amid Democrat socialist surge (Far Right — BizPac Review)
- MAGA reporter declares: 'Uncool' State Fair debacle is the 'end of Trump' (Left — Alternet.org)
- Karoline Leavitt warns ‘full-blown Communist revolution’ taking place right NOW (Far Right — BizPac Review)
- Pay-to-play cycle behind GOP's corporate tax cuts exposed in new report (Far Left — Raw Story)
More Headlines From March 10, 2026
- Pendulum swings back on economy amid Iran conflict (Center)
- Georgia voters deciding Marjorie Taylor Greene's replacement in special election (Center)
- Oil prices fall and stocks rebound after Trump says Iran war could end ‘very soon’ (Center Left)
- Gas price spikes are slamming Senate battleground states (Center Left)
- Oil prices fluctuate as Trump signals Iran conflict could end soon (Center)








